Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (481-490 of 869) with videos related to

Pageof 87
Sort By:
Blood|September 10, 2005
Dysfunctional T regulatory cells in multiple myelomaRao H Prabhala, Paola Neri, Jooeun E Bae, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2019
Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple MyelomaSundar Jagannath, Leonard T Heffner, Sikander Ailawadhi, et al.
Oncotarget|October 21, 2016
A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applicationsJana Jakubikova, Danka Cholujova, Teru Hideshima, et al.
Cancer Research|December 18, 2003
Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myelomaTeru Hideshima, Dharminder Chauhan, Toshiaki Hayashi, et al.
British Journal of Haematology|April 17, 2004
Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myelomaNoopur Raje, Teru Hideshima, Faith E Davies, et al.
Blood|November 20, 2008
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signalingMarc S Raab, Iris Breitkreutz, Giovanni Tonon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
Novel therapies in the treatment of multiple myelomaJacob P Laubach, Constantine S Mitsiades, Anuj Mahindra, et al.
Blood|March 25, 2016
Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1Paul G Richardson, Todd M Zimmerman, Craig C Hofmeister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2008
Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX studyAsher Chanan-Khan, Pieter Sonneveld, Michael W Schuster, et al.
Blood|July 10, 2013
A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemiaGuang Yang, Yangsheng Zhou, Xia Liu, et al.
Pageof 87

Showing results (481-490 of 869) with videos related to

Sort By:
Pageof 87
Blood|September 10, 2005
Dysfunctional T regulatory cells in multiple myelomaRao H Prabhala, Paola Neri, Jooeun E Bae, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2019
Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple MyelomaSundar Jagannath, Leonard T Heffner, Sikander Ailawadhi, et al.
Oncotarget|October 21, 2016
A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applicationsJana Jakubikova, Danka Cholujova, Teru Hideshima, et al.
Cancer Research|December 18, 2003
Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myelomaTeru Hideshima, Dharminder Chauhan, Toshiaki Hayashi, et al.
British Journal of Haematology|April 17, 2004
Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myelomaNoopur Raje, Teru Hideshima, Faith E Davies, et al.
Blood|November 20, 2008
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signalingMarc S Raab, Iris Breitkreutz, Giovanni Tonon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
Novel therapies in the treatment of multiple myelomaJacob P Laubach, Constantine S Mitsiades, Anuj Mahindra, et al.
Blood|March 25, 2016
Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1Paul G Richardson, Todd M Zimmerman, Craig C Hofmeister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2008
Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX studyAsher Chanan-Khan, Pieter Sonneveld, Michael W Schuster, et al.
Blood|July 10, 2013
A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemiaGuang Yang, Yangsheng Zhou, Xia Liu, et al.
Pageof 87